Summary
Heparin-binding epidermal growth factor (EGF)-like growth factor is a 22-kDa glycoprotein that was originally identified as a secreted product of cultured human macrophages. Although the growth factor mRNA has been identified in various cells and tissues, the tissue distribution of the protein itself has rarely been demonstrated. In this study, the EGF-like growth factor was detected immunohistochemically in a variety of human skin samples by indirect immunofluorescence using a polyclonal rabbit antiserum raised against residues 26–41 of mature heparin-binding EGF. The keratinocytes of a variety of epithelium-derived structures demonstrated reproducible, specific staining for the EGF. In normal tissues, this staining was prominent in the basal cells of the epidermis and in the epithelial cells lining epidermal appendages such as hair follicles, sebaceous sweat glands and eccrine sweat glands. In addition, specific staining was detected in skin cancers derived from the basal epithelial cell layer, including basal and squamous cell carcinomas of the skin, with no staining detected in melanoma specimens. Immunoreactive heparin-binding EGF was characteristically associated with the surface of cells. With minor exceptions, the immunoreactive sites are identical to the known EGF receptor distribution in the skin, and suggest that keratinocyte-derived heparin-binding EGF may act in concert with other EGF family members in processes such as skin morphogenesis and wound repair, as well as in the development of skin cancers
Similar content being viewed by others
References
Abraham, J.A., Damm, D., Bajardi, A., Miller, J., Klagsbrun, M. & Ezekowitz, R.A.B. (1993) Heparin-binding EGF-like growth factor: characterization of rat and mouse CDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochem. Biophys. Res. Commun.190, 125-33.
Aviezer, D. & Yayon, A. (1994) Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Proc. Natl Acad. Sci. USA.91, 12173-7.
Bauknecht, T., Gross, G. & Hagedorn, M. (1985) Epidermal growth factor receptors in different skin tumors. Dermatologica171, 16-20.
Besner, G.E., Higashiyama, S. & Klagsbrun, M. (1990) Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul.1, 811-9.
Besner, G.E., Whelton, D., Crissman-combs, M., Steffen, C., Kim, G., & Brigstock, D.R. (1992) Interaction of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: modulation by heparin, heparinase or synthetic heparin-binding HB-EGF fragments. Growth Factors7, 289-96.
Brown, G.L., Nanney, L.B., Griffen, J., Cramer, A.B., Yancey, J.M., Curtsinger, L.J., Holtzin, L., Schultz, G.S., Kurkiewicz, M.J. & Lynch, J.B. (1989) Enhancement of wound healing by topical treatment with epidermal growth factor. N. Engl. J. Med.321, 76-9.
Cook, P., Damm, D., Garrick, B., Wood, K., Karkaria, C., Higashiyama, S., Klagsbrun, M. & Abraham, J. (1995a). Carboxyl-terminal truncation of Leucine76 converts heparin-binding EGF-like growth factor from a heparin-enhancible growth factor to a heparin-suppressible growth factor. J. Cell Physiol.163, 407-17.
Cook, P., Ashton, M., Karkaria, C., Seiss, D. & Shipley, G. (1995b) Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity. J. Cell Physiol.163, 418-29.
Davis, K.M., Brigstock, D.R., Johnson, P.R., Crissman-combs, M.A., Mccarthy, D.W., Downing, M.T. & Besner, G.E. (1996) Production of glycosylated heparin-binding EGF-like growth factor in HeLa cells usin vaccinia virus. Prot. Express. Purifica.8, 57-7.
Dominey, A.M., Wang, X.J., King, L.E., Nanney, L.B., Gagne, T.A., Sellheter, K., Bundman, D.S., Longley, M.A., Rothnagel, J.A. & Greenhalgh, D.A. (1993) Targeted overexpression of transforming growth factor α in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Diff.4, 1071-82.
Elder, J.T., Fisher, G.J., Lindquist, P.B., Bennett, G.L., Pittelkow, M.R., Coffey, R.J., Ellingsworth, L., Derynck, R. & Voorhees, J.J. (1989) Overexpression of transforming growth factor alpha in psoriatic epidermis. Science243, 811-14.
Elder, J.T., Klein, S.B., Tavakkol, A., Fisher, G.J., Nickoloff, B.J. & Voorhees, J.J. (1990) Growth factor and proto-oncogene expression in psoriasis. J. Invest. Dermatol.95, 7S-9S.
Hashimoto, K., Higashiyama, S., Asada, H., Hashimura, E., Kobayashi, T., Sudo, K., Nakagawa, T., Damm, D., Yoshikawa, K. & Taniguchi, N. (1994) Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J. Biol. Chem.269, 20060-6.
Higashiyama, S., Abraham, J.A., Miller, J., Fiddes, J.C. & Klagsbrun, M. (1991) A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science251, 936-9.
Higashiyama, S., Lau, K., Besner, G.E., Abraham, J.A. & Klagsbrun, M. (1992) Structure of heparin-binding EGF-like growth factor. Multiple forms primary structure, and glycosylation of the mature protein. J. Biol. Chem.267, 6205-12.
Higashiyama, S., Abraham, J. & Klagsbrun, M. (1993) Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J. Cell. Biol.122, 933-40.
Kim, G., Besner, G., Steffen, C., Mccarthy, D., Downing, M., Luquette, M., Abad, M. & Brigstock, D. (1995) Purification of heparin-binding EGF-like growth factor from pig uterine luminal flushings, and its production by endometrial tissues. Biol. Reprod.52, 561-71.
Kiso, S., Kawata, S., Tamura, S., Higashiyama, S., Ito, N., Tsushima, H., Taniguchi, N. & Matsuzawa, Y. (1995) Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy. Hepatology22, 1584-90.
Kobrin, M.S., Funatomi, H., Friess, H., Buchler, M.W., Stathis, P. & Korc, M. (1994) Induction and epxression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem. Biophys. Res. Commun.202, 1705-9.
Marikovsky, M., Breuing, K., Liu, P.Y., Eriksson, E., Higashiyama, S., Farber, P., Abraham, J. & Klagsbrun, M. (1993) Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc. Natl Acad. Sci. USA.90, 3889-93.
Marikovsky, M., Vogt, P., Eriksson, E., Rubin, J.S., Taylor, W.G., Sasse, J. & Klagsbrun, M. (1996) Wound fluid derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-1 for Balb/MK keratinocyte proliferation. J. Investig. Dermatol.106, 616-21.
Miyoshi, E., Higashiyama, S., Nakagawa, T., Suzuki, K., Horimoto, M., Hayashi, N., Fusamoto, H., Kamada, H., Kamada, T. & Taniguchi, N. (1996) High expression of heparin-binding EGF-like growth factor in rat hepatocarcinogenesis. Int. J. Cancer68, 215-18.
Murayama, Y., Miyagawa, J.-I., Higashiyama, S., Kondo, S., Yabu, M., Isozaki, K., Kayanoki, Y., Kanayama, S., Shinomura, Y., Taniguchi, N. & Matsuzawa, Y. (1995) Localization of heparin-binding epidermal growth factor-like growth factor in human gastric mucosa. Gastroenterology109, 1051-9.
Naef, M., Yokoyama, M., Friess, H., Buchler, M.W. & Korc, M. (1996) Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma. Int. J. Cancer66, 315-21.
Naglich, J.G., Metherall, J.E., Russell, D.W. & Eidels, L. (1992) Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell69, 1051-61.
Nanney, L.B., Magid, M., Stoscheck, C.M. & King, L.E. (1994) Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J. Investig. Dermatol.83, 385-93.
Nanney, L.B., Stoscheck, C.M., Magid, M. & King, L.E. (1986) Altered 125I-epidermal growth factor binding and receptor distribution in psoriasis. J. Invest. Dermatol.86, 260-5.
Ono, M., Raab, G., Lau, K., Abraham, J. & Klagsbrun, M. (1994) Purification and characterization of transmembrane froms of herapin-binding EGF-like growth factor. J. Biol. Chem.269, 31315-21.
Ozanne, B. & Richards, C.S. (1986) Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas. J. Pathol.149, 9-14.
Powell, P.P., Klagsbrun, M., Abraham, J.A. & Jones, R. (1993) Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am. J. Pathol.143, 784-93.
Prigent, S.A. & Lemoine, N.R. (1992) The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog. Growth Factor Res.4, 1-24.
Schultz, G., Rotatori, S. & Clark, W. (1991) EGF and TGF-α in wound healing and repair. J. Cell. Biochem.45, 346-52.
Turbitt, M.L., Akhurst, R.J., White, S.I. & Mackie, R.M. (1990) Localization of elevated transforming growth factor-alpha in psoriatic epidermis. J. Invest. Dermatol.95, 229-32.
Vassar, R. & Fuchs, E. (1991) Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes Develop.5, 714-27.
Vassar, R., Hutton, E. & Fuchs, E. (1992) Transgenic overexpression of transforming growth factor α bypasses the need for c-HA-ras mutations in mouse skin tumorigenesis. Mol. Cell Biol.12, 4643-53.
Vaughan, T.J., Pascall, J.C. & Brown, K.D. (1992) Tissue distribution of mRNA for heparin-binding epidermal growth factor. Biochem. J.287, 681-4.
Yates, R.A., Nanney, L.B., Gates, R.E. & King, L.E. (1991) Epidermal growth factor and related growth factors. Inter. J. Dermatol.30, 687-94.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Downing, M.T., Brigstock, D.R., Luquette, M.H. et al. Immunohistochemical localization of heparin-binding epidermal growth factor-like growth factor in normal skin and skin cancers. J Mol Hist 29, 735–744 (1997). https://doi.org/10.1023/A:1026417202351
Issue Date:
DOI: https://doi.org/10.1023/A:1026417202351